These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8183019)

  • 1. [Estrogen therapy. Is breast cancer a contraindication to hormonal substitution therapy?].
    von Schoultz E; Wilking N; Rutqvist LE; Theve T; von Schoultz B
    Lakartidningen; 1994 Mar; 91(13):1302-6. PubMed ID: 8183019
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hormone-dependent oncological diseases in menopausal women].
    Tomov S; Baichev G; Gorchev G
    Akush Ginekol (Sofiia); 2000; 39(3):41-5. PubMed ID: 11187996
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormone replacement therapy and breast cancer risk.
    Burke CC; Gullatte MM; Vigliani M; Ruggiero RJ; Esserman L; Crawford B
    Cancer Pract; 1997; 5(4):203-8. PubMed ID: 9250076
    [No Abstract]   [Full Text] [Related]  

  • 4. Postmenopausal estrogen replacement therapy in the patient with breast carcinoma.
    Cyr MG
    R I Med; 1995 Sep; 78(9):261-3. PubMed ID: 7579723
    [No Abstract]   [Full Text] [Related]  

  • 5. Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group.
    Cobleigh MA; Berris RF; Bush T; Davidson NE; Robert NJ; Sparano JA; Tormey DC; Wood WC
    JAMA; 1994 Aug; 272(7):540-5. PubMed ID: 8046809
    [No Abstract]   [Full Text] [Related]  

  • 6. Estrogen replacement therapy in women with previously treated breast cancer. ACOG Committee Opinion: Committee on Gynecologic Practice Number 135-April 1994.
    Int J Gynaecol Obstet; 1994 May; 45(2):184-8. PubMed ID: 7915695
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormonal therapy and genital tract cancer.
    Wren B
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):38-41. PubMed ID: 8777257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is estrogen replacement therapy contraindicated in breast cancer?].
    Iversen OE
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):611-2. PubMed ID: 16505873
    [No Abstract]   [Full Text] [Related]  

  • 9. [Estrogen replacement in women treated for breast cancer].
    Bertelsen CA; Andreasson B; Lidegaard O
    Ugeskr Laeger; 1998 Nov; 160(48):6954-7. PubMed ID: 9846089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations regarding estrogen replacement therapy after treatment of endometrial cancer.
    Creasman WT
    Oncology (Williston Park); 1992 Jul; 6(7):23-6; discussion 26, 28. PubMed ID: 1386238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estrogen and breast cancer].
    Marckmann A
    Ugeskr Laeger; 1999 Mar; 161(9):1287-8. PubMed ID: 10083833
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormone replacement therapy and estrogen-dependent cancers.
    Birkhäuser M
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():99-114. PubMed ID: 7874193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormone therapy and risk for breast cancer in Finnish postmenopausal women].
    Lyytinen H; Ylikorkala O
    Duodecim; 2011; 127(3):235-42. PubMed ID: 21438346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormone replacement therapy and cancer of the breast. 2. Should a woman with cancer of the breast receive hormone replacement therapy?].
    Ayres de Campos D; Cardoso MJ; Martinez de Oliveira J
    Acta Med Port; 1997 Oct; 10(10):705-11. PubMed ID: 9477596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menopausal hormone therapy after breast cancer.
    Colditz GA
    Breast Cancer Res; 2005; 7(4):168-70. PubMed ID: 15987471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of tamoxifen in postmenopause.
    Sismondi P; Biglia N; Giai M; Sgro L; Campagnoli C
    Anticancer Res; 1994; 14(5B):2237-44. PubMed ID: 7840529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
    Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
    Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaginal oestrogen therapy in women with hormone-sensitive breast cancer].
    Bak AM; Laursen BE; Rungby J; Brock B
    Ugeskr Laeger; 2011 Feb; 173(9):648-51. PubMed ID: 21362392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment, aromatase inhibitors, and age.
    Tralongo P; Di Mari A; Ferrau' F
    J Clin Oncol; 2005 Jun; 23(18):4243. PubMed ID: 15961782
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormone replacement therapy after breast cancer: attitudes of women eligible in a randomized trial.
    Wallberg B; von Schoultz E; Bolund C; Bergh J; Wilking N
    Climacteric; 2009 Dec; 12(6):478-89. PubMed ID: 19905900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.